Researchers identified three different MINAR2 genetic mutations that were responsible for deafness in 13 people from four different families.
Human cortical networks have evolved a novel neural network that relies on abundant connections between inhibitory interneurons.
Maternal autoantibody–related autism spectrum disorder (MAR ASD) is marked by specific maternal antibodies that react to certain proteins in the fetal brain. Examining the plasma of expecting mothers, researchers found mothers with reactivity to one of the nine MAR ASD patterns were eight times as likely to have a child diagnosed with autism.
Researchers report acupuncture may help alleviate symptoms for sufferers of chronic tension headaches.
At some point, we all face social rejection. Researchers say that while rejection affects us all differently, it's how respond to the setback that determines how rejection affects us.
The amygdala-pons connectivity in the pons-corticolimbic network is significantly stronger in patients with major depressive disorder.
Disabling activity in an area of the brain stem called the area postrema reduces nausea, while activating this area promotes vomiting, a new study reveals. The findings could lead to the development of new therapies to curb nausea.
Study identifies a specific protein in sensory neurons that detects mechanical itch stimuli such as an insect crawling on the skin or when one touches an object that irritates the skin.
Researchers discovered both immune system and central nervous system dysfunction in animal models and people with ALS4, a genetic, juvenile, and slow-progressing form of ALS.
Study reveals the role of the urea cycle in the brain and explores the dual nature of astrocytes in the brains of those with Alzheimer's pathology.
People who are more determined, or express more "grit" have different patterns of cognitive performance, researchers say. However, having more grit does not necessarily translate into having better cognitive performance.
Study reveals 27.8% of pain medications with high abuse potential make it all the way through the development process, compared to only 4.7% of medications with lower potential for abuse.
